Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-17-037516

EVP, Chief Financial Officer acquired 8,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bell Graeme · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-02 Grant or award : show line 1 in the form +8,400 $12.37 $103,938 8,400 D
Loading xslF345X03/doc4.xml…